LORD, ABBETT & CO. LLC - GENMAB A/S ownership

GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 211 filers reported holding GENMAB A/S in Q1 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of GENMAB A/S
ValueSharesWeighting
Q4 2022$27,358
-99.5%
645,551
+279.8%
0.10%
+390.0%
Q3 2022$5,461,000
-24.0%
169,972
-23.1%
0.02%
-20.0%
Q2 2022$7,183,000
-0.3%
221,085
+11.0%
0.02%
+31.6%
Q1 2022$7,205,000
-12.9%
199,154
-4.7%
0.02%0.0%
Q4 2021$8,270,000
-11.7%
209,062
-2.5%
0.02%
-13.6%
Q3 2021$9,368,000
+0.7%
214,362
-5.9%
0.02%0.0%
Q2 2021$9,299,000
+133.8%
227,737
+88.0%
0.02%
+120.0%
Q1 2021$3,977,000121,1310.01%
Other shareholders
GENMAB A/S shareholders Q1 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 214,848$6,980,0002.38%
Cutter & CO Brokerage, Inc. 119,956$3,897,0001.33%
Hardman Johnston Global Advisors LLC 933,449$30,328,0001.29%
Connective Portfolio Management, LLC 18,000$585,0001.00%
Capricorn Fund Managers Ltd 148,411$4,822,0000.88%
TORRAY INVESTMENT PARTNERS LLC 131,708$4,279,0000.82%
First Light Asset Management, LLC 160,885$5,227,0000.61%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 1,857$57,189,0000.60%
Yorktown Management & Research Co Inc 10,100$328,0000.42%
Integrated Investment Consultants, LLC 18,550$602,0000.22%
View complete list of GENMAB A/S shareholders